Health
your username
15 hours ago
Athira Pharma, Inc. and its CEO, Leen Kawas, were sued by two groups of stockholder plaintiffs Friday. The first suit, by plaintiffs Fan Wang and Hang Gao, was brought over claims that the company violated federal securities laws and defrauded its investors through misleading statements about the status of the company.
The plaintiffs have requested class certification for all investors who held stock in Athira between September 2020 and June 17, 2021. The plaintiffs are demanding a trial by jury, and ultimately seeking punitive and compensatory damages, litigation costs, as well as any other relief the court may deem just and proper. The case was filed Friday in the Western District of Washington.
Athira Pharma Sued by Two Sets of Stockholders After CEO Placed on Leave lawstreetmedia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lawstreetmedia.com Daily Mail and Mail on Sunday newspapers.